Literature DB >> 25143633

Oestrogen, ocular function and low-level vision: a review.

Claire V Hutchinson1, James A Walker2, Colin Davidson2.   

Abstract

Over the past 10 years, a literature has emerged concerning the sex steroid hormone oestrogen and its role in human vision. Herein, we review evidence that oestrogen (oestradiol) levels may significantly affect ocular function and low-level vision, particularly in older females. In doing so, we have examined a number of vision-related disorders including dry eye, cataract, increased intraocular pressure, glaucoma, age-related macular degeneration and Leber's hereditary optic neuropathy. In each case, we have found oestrogen, or lack thereof, to have a role. We have also included discussion of how oestrogen-related pharmacological treatments for menopause and breast cancer can impact the pathology of the eye and a number of psychophysical aspects of vision. Finally, we have reviewed oestrogen's pharmacology and suggest potential mechanisms underlying its beneficial effects, with particular emphasis on anti-apoptotic and vascular effects.
© 2014 Society for Endocrinology.

Entities:  

Keywords:  eye; menopause; oestrogen; vision

Mesh:

Substances:

Year:  2014        PMID: 25143633     DOI: 10.1530/JOE-14-0349

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  10 in total

1.  Visual impairment at baseline is associated with future poor physical functioning among middle-aged women: The Study of Women's Health Across the Nation, Michigan Site.

Authors:  Navasuja Chandrasekaran; Sioban Harlow; Sayoko Moroi; David Musch; Qing Peng; Carrie Karvonen-Gutierrez
Journal:  Maturitas       Date:  2016-11-15       Impact factor: 4.342

Review 2.  Evidence for Menopause as a Sex-Specific Risk Factor for Glaucoma.

Authors:  Amber Douglass; Michael Dattilo; Andrew J Feola
Journal:  Cell Mol Neurobiol       Date:  2022-01-04       Impact factor: 4.231

3.  Natural variation in female reproductive hormones does not affect contrast sensitivity.

Authors:  Abigail L M Webb; Paul B Hibbard; Rick O'Gorman
Journal:  R Soc Open Sci       Date:  2018-02-28       Impact factor: 2.963

4.  Preliminary data for performance in hue ordering tests during pregnancy.

Authors:  T S S Calandrini; L Miquilini; M R Laranjeiras-Neto; M T S Tongu; M P Silva; G S Souza; M I T Cortes
Journal:  Braz J Med Biol Res       Date:  2019-01-24       Impact factor: 2.590

Review 5.  Leveraging Nuclear Receptors as Targets for Pathological Ocular Vascular Diseases.

Authors:  Pei-Li Yao; Jeremy Peavey; Goldis Malek
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

6.  Successful induction of diabetes in mice demonstrates no gender difference in development of early diabetic retinopathy.

Authors:  Aicha Saadane; Emma M Lessieur; Yunpeng Du; Haitao Liu; Timothy S Kern
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

7.  Surgical Menopause Impairs Retinal Conductivity and Worsens Prognosis in an Acute Model of Rat Optic Neuropathy.

Authors:  Edyta Olakowska; Piotr Rodak; Anna Pacwa; Joanna Machowicz; Bartosz Machna; Joanna Lewin-Kowalik; Adrian Smedowski
Journal:  Cells       Date:  2022-09-29       Impact factor: 7.666

8.  Visual disorders and mal de debarquement syndrome: a potential comorbidity questionnaire-based study.

Authors:  Cherylea J Browne; Paul Fahey; Stella R Sheeba; Margie H Sharpe; Mark Rosner; Debby Feinberg; Viviana Mucci
Journal:  Future Sci OA       Date:  2022-09-14

Review 9.  Gonadal Hormones and Retinal Disorders: A Review.

Authors:  Raffaele Nuzzi; Simona Scalabrin; Alice Becco; Giancarlo Panzica
Journal:  Front Endocrinol (Lausanne)       Date:  2018-03-02       Impact factor: 5.555

10.  The Association Between Genetic Polymorphisms in Estrogen Receptor Genes and the Risk of Ocular Disease: A Meta-Analysis

Authors:  Zulvikar Syambani Ulhaq
Journal:  Turk J Ophthalmol       Date:  2020-08-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.